Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications metabolically healthy obesity risk incident ischemic heart disease stroke ���
… respiratory syncytial virus (RSV) diagnosis, outcomes, and risk factors by race, ethnicity, and other social …
… scores and other covariates Analyses to compare the risk of deterioration in HRQOL between treatment groups and …
… their physician and nonphysician counterparts, building risk stratified mortality predictive models, evaluating … determinants of health data and applying them to social risk stratification and population health and health equity …
… decisions. Related Services Pharmacoepidemiology and Risk Management Staff Members Julia Vila Guilera Xabier …
… immunoglobulin levels among B-cell–depleting therapies and risk of infections in relapsing multiple sclerosis. Saidha S, …
… signs and symptoms of respiratory syncytial virus in high-risk adults and immunocompromised populations. Costello J, …
… to accept adverse event and cost trade-offs for reduced risk of non-melanoma skin cancer. Skelsey MK, Okun MM, Schiro …
Global Forum for Qualified Persons for Pharmacovigilance (QPPV) Share on: Tuesday, November 8 - Wednesday, November 9, 2022 Event website Alejandro Arana will be presenting an epidemiologist perspective on true adverse reactions in pharma research at the …
… Julia Vila Guilera Pharmacoepidemiology and Risk Management Barcelona, Spain PhD, Global Health MSc, … a Research Epidemiologist in the Pharmacoepidemiology and Risk Management group in Barcelona, Spain, with RTI-HS. Dr. …
… of life and tolerability of loncastuximab tesirine in high-risk patients with relapsed/refractory diffuse large B-cell …